Evidence map›Paper›PMID 31173667›Full record

ArticleJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2019

Expression of a Degradation-Resistant β-Catenin Mutant in Osteocytes Protects the Skeleton From Mechanodeprivation-Induced Bone Wasting.

Whitney A Bullock, April M Hoggatt, Daniel J Horan, Karl J Lewis, Hiroki Yokota, Steven Hann, Matthew L Warman, Aimy Sebastian, Gabriela G Loots, Fredrick M Pavalko and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Notum Deletion From Late-Stage Skeletal Cells Increases Cortical Bone Formation and Potentiates Skeletal Effects of Sclerostin Inhibition.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2021
    Article
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Whitney A BullockDepartment of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN, USA.ORCID 0000-0001-9008-8314
April M HoggattDepartment of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN, USA.
Daniel J HoranDepartment of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN, USA.
Karl J LewisDepartment of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN, USA.
Hiroki YokotaDepartment of Biomedical Engineering, Indiana University-Purdue University at Indianapolis, Indianapolis, IN, USA.
Steven HannDepartment of Orthopaedic Surgery, Boston Children's Hospital, Boston, MA, USA.
Matthew L WarmanDepartment of Orthopaedic Surgery, Boston Children's Hospital, Boston, MA, USA.
Aimy SebastianBiology and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, CA, USA.
Gabriela G LootsBiology and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, CA, USA.
Fredrick M PavalkoDepartment of Integrative and Cellular Physiology, Indiana University School of Medicine, Indianapolis, IN, USA.
Alexander G RoblingDepartment of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN, USA.
Indiana University School of MedicineBoston Children's Hospital · USLawrence Livermore National Laboratory · USUniversity of Indianapolis · USIndiana Hemophilia and Thrombosis Center · US

Funding

Lrp5 signaling in bone mechanotransduction and metabolismR01AR053237 · NIAMS · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI ALEXANDER G ROBLING, Matthew L Warman · 2005 to 2026
$9.4M
Comprehensive Training Program in Musculoskeletal ResearchT32AR065971 · NIAMS · INDIANA UNIVERSITY INDIANAPOLIS · PI ALEXANDER G ROBLING · 2015 to 2026
$4.4M
Role of Src Kinase in Mechanically-Induced Bone FormationR01AR069029 · NIAMS · INDIANA UNIVERSITY INDIANAPOLIS · PI PAVALKO, FREDRICK M, ROBLING, ALEXANDER G · 2017 to 2021
$2.6M
MECHANISMS OF INHIBITING BONE FORMATION THROUGH ANTAGONISMR01DK075730 · NIDDK · UNIVERSITY OF CALIF-LAWRNC LVRMR NAT LAB · PI LOOTS, GABRIELA G · 2009 to 2013
$1.8M
Lrp5 and Lrp6 signaling in bone mechanotransduction and metabolismR56AR053237 · NIAMS · INDIANA UNIVERSITY INDIANAPOLIS · PI ROBLING, ALEXANDER G, WARMAN, MATTHEW L · 2023 to 2023
$349k
Accessory Membrane and Intracellular Mediators in Bone Cell MechanotransductionF31AR070624 · NIAMS · INDIANA UNIVERSITY INDIANAPOLIS · PI BULLOCK, WHITNEY · 2017 to 2019
$93k
BLRD Research Career Scientist Award ApplicationIK6BX003783 · VA · RLR VA MEDICAL CENTER · PI ALEXANDER G ROBLING · 2017 to 2026
–
Improving bone health by harnessing the anabolic potential of LDL receptor relateI01BX001478 · VA · RLR VA MEDICAL CENTER · PI ROBLING, ALEXANDER G · 2012 to 2025
–
BLRD VA I01 BX001478BLRD VA IK6 BX003783NIAMS NIH HHS F31 AR070624NIAMS NIH HHS R01 AR053237NIAMS NIH HHS R01 AR069029NIAMS NIH HHS R56 AR053237NIAMS NIH HHS T32 AR065971NIDDK NIH HHS R01 DK075730NIH HHS AR053237NIH HHS AR065971NIH HHS AR069029NIH HHS AR070624NIH HHS DK075730
6 · The paper itself

Abstract

Mechanical stimulation is a key regulator of bone mass, maintenance, and turnover. Wnt signaling is a key regulator of mechanotransduction in bone, but the role of β-catenin-an intracellular signaling node in the canonical Wnt pathway-in disuse mechanotransduction is not defined. Using the β-catenin exon 3 flox (constitutively active [CA]) mouse model, in conjunction with a tamoxifen-inducible, osteocyte-selective Cre driver, we evaluated the effects of degradation-resistant β-catenin on bone properties during disuse. We hypothesized that if β-catenin plays an important role in Wnt-mediated osteoprotection, then artificial stabilization of β-catenin in osteocytes would protect the limbs from disuse-induced bone wasting. Two disuse models were tested: tail suspension, which models fluid shift, and botulinum-toxin (botox)-induced muscle paralysis, which models loss of muscle force. Tail suspension was associated with a significant loss of tibial bone mass and density, reduced architectural properties, and decreased bone formation indices in uninduced (control) mice, as assessed by dual-energy X-ray absorptiometry (DXA), micro-computed tomography (µCT), and histomorphometry. Activation of the βcatCA allele in tail-suspended mice resulted in little to no change in those properties; ie, these mice were protected from bone loss. Similar protective effects were observed among botox-treated mice when the βcatCA was activated. RNAseq analysis of altered gene regulation in tail-suspended mice yielded 35 genes, including Wnt11, Gli1, Nell1, Gdf5, and Pgf, which were significantly differentially regulated between tail-suspended β-catenin stabilized mice and tail-suspended nonstabilized mice. Our findings indicate that selectively targeting/blocking of β-catenin degradation in bone cells could have therapeutic implications in mechanically induced bone disease. © 2019 American Society for Bone and Mineral Research.

Indexed as

Mechanotransduction, CellularOsteogenesisAnimalsbeta CateninBone DensityMiceMice, TransgenicOsteocytesTibiaX-Ray Microtomographybeta CateninCTNNB1 protein, mouseCTNNB1DISUSEOSTEOPOROSISWNTβ-CATENIN

Identifiers

PMID31173667
PMCPMC6813861
OpenAlexW2957528352

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.